^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners

TEST:
cobas® KRAS Mutation Test

Company:
Roche
Type:
FDA Approved
Related tests:
The cobas® KRAS Mutation Test, for use with the cobas® 4800 System, is a real-time PCR test for the detection of seven somatic mutations in codons 12, 13 and 61 of the KRAS gene in DNA derived from formalin-fixed paraffin-embedded human colorectal cancer (CRC) tumor tissue. The test is intended to be used as an aid in the identification of CRC patients for whom treatment with Erbitux® (cetuximab) or with Vectibix® (panitumumab) may be indicated based on a no mutation detected result. Specimens are processed using the cobas® DNA Sample Preparation Kit for manual sample preparation and the cobas z 480 analyzer for automated amplification and detection.
Cancer:
Colorectal Cancer
Gene:
KRAS (KRAS proto-oncogene GTPase)
Drug:
Erbitux (cetuximab), Vectibix (panitumumab)
Method:
PCR
Approvals
Date
Cancer
Gene
Drug
By
Confirmatory trial(s)